We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+1.9%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$559M
AUM Growth
-$480M
(-46%)
Cap. Flow
-$438M
Cap. Flow
% of AUM
-78.37%
Top 10 Holdings %
Top 10 Hldgs %
15.86%
Holding
756
New
216
Increased
66
Reduced
143
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLK
Allakos
ALLK
|
+$25.1M |
| 2 |
Merck
MRK
|
+$9.57M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$9.37M |
| 4 |
BridgeBio Pharma
BBIO
|
+$9.02M |
| 5 |
Marvell Technology
MRVL
|
+$7.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$10.5M |
| 2 |
Citigroup
C
|
+$10.5M |
| 3 |
Microsoft
MSFT
|
+$9.87M |
| 4 |
OPTU
Optimum Communications Inc
OPTU
|
+$9.41M |
| 5 |
AES
AES
|
+$7.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.93% |
| 2 | Consumer Discretionary | 17.95% |
| 3 | Healthcare | 12.14% |
| 4 | Communication Services | 8.7% |
| 5 | Financials | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Archer Daniels Midland
ADM
$37.4B
| $777K | 0.14% |
11,498
-23,735
| -67% | -$1.53M |
|
202
Coca-Cola Europacific Partners
CCEP
$48B
| $761K | 0.14% |
13,607
+8,079
| +146% | +$436K |
|
203
Envista
NVST
$4.66B
| $755K | 0.14% |
+16,759
| New | +$689K |
|
204
NIO
NIO
$11.7B
| $747K | 0.13% |
+23,590
| New | +$867K |
|
205
Honeywell
HON
$78.6B
| $745K | 0.13% |
+3,793
| New | +$766K |
|
206
Occidental Petroleum
OXY
$53.5B
| $742K | 0.13% |
25,593
+7,575
| +42% | +$238K |
|
207
Leidos
LDOS
$16B
| $737K | 0.13% |
+8,285
| New | +$776K |
|
208
Vermilion Energy
VET
$1.61B
| $735K | 0.13% |
+58,350
| New | +$635K |
|
209
Domino's
DPZ
$12.1B
| $731K | 0.13% |
+1,296
| New | +$659K |
|
|
EMBJ
210
Embraer S.A. ADS
EMBJ
$13B
| $727K | 0.13% |
40,984
-115,793
| -74% | -$1.87M |
|
|
EDR
211
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $724K | 0.13% |
+20,757
| New | +$587K |
|
212
First Majestic Silver
AG
$8.68B
| $720K | 0.13% |
64,787
-216,310
| -77% | -$2.61M |
|
213
Veeva Systems
VEEV
$34.7B
| $719K | 0.13% |
+2,814
| New | +$818K |
|
|
ONEM
214
DELISTED
1Life Healthcare
ONEM
| $704K | 0.13% |
40,065
-33,622
| -46% | -$652K |
|
215
Genuine Parts
GPC
$18.1B
| $688K | 0.12% |
4,910
-942
| -16% | -$125K |
|
|
ENDP
216
DELISTED
Endo International plc
ENDP
| $687K | 0.12% |
+182,734
| New | +$885K |
|
217
Ball Corp
BALL
$16.9B
| $683K | 0.12% |
7,096
+1,051
| +17% | +$97.2K |
|
218
Playboy Inc
PLBY
$134M
| $683K | 0.12% |
+25,639
| New | +$775K |
|
219
Synchrony
SYF
$25.8B
| $682K | 0.12% |
+14,710
| New | +$707K |
|
|
WBA
220
DELISTED
Walgreens Boots Alliance
WBA
| $682K | 0.12% |
13,069
-70,411
| -84% | -$3.41M |
|
221
Warner Music
WMG
$13.6B
| $678K | 0.12% |
15,699
+6,999
| +80% | +$315K |
|
222
Brookfield Infrastructure
BIPC
$4.94B
| $677K | 0.12% |
+14,873
| New | +$616K |
|
223
CSX Corp
CSX
$94.7B
| $676K | 0.12% |
17,987
-45,011
| -71% | -$1.59M |
|
224
Huntsman Corp
HUN
$1.78B
| $673K | 0.12% |
+19,301
| New | +$630K |
|
225
Olin
OLN
$2.13B
| $671K | 0.12% |
+11,666
| New | +$654K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Seven Eight Capital held 756 positions worth $559M, down 46% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Seven Eight Capital withdrew a net $438M in Q4 2021, closing 331 positions and reducing 143 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Seven Eight Capital opened a new position in Allakos worth $3M.
- Seven Eight Capital's largest Q4 2021 buy was Allakos: 306,723 shares worth $3M.
- Seven Eight Capital added most to Mimecast Limited in Q4 2021, an estimated $6.07M increase.
- Seven Eight Capital's biggest Q4 2021 reduction was Fidelity National Information Services, cutting an estimated $7.12M.
- Seven Eight Capital fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $10.5M.
- Seven Eight Capital's ten largest holdings make up 16% of its $559M portfolio in Q4 2021.
- Seven Eight Capital opened 216 new positions and closed 331 in Q4 2021.
- Seven Eight Capital's portfolio value fell 46% quarter-over-quarter to $559M.
Based on Seven Eight Capital's 13F filing for Q4 2021, filed 14 Feb 2022.